Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia

Njunge J. et al, (2025)

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.

Terstappen J. et al, (2024), Lancet Infect Dis, 24, e747 - e761

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023.

Mwanga MJ. et al, (2023), Emerg Infect Dis, 29, 2376 - 2379

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.

Green C. et al, (2023), Clin Exp Immunol, 211, 269 - 279

A new Omicron lineage with Spike Y451H mutation that dominated a new COVID-19 wave in Kilifi, Coastal Kenya: March-May 2023

Mwanga M. et al, (2023)

Enrichment approach for unbiased sequencing of respiratory syncytial virus directly from clinical samples.

Waweru JW. et al, (2021), Wellcome open research, 6

Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).

Jefferies K. et al, (2020), The Journal of infectious diseases

Include forthcoming?